TREVER WEAVER: Open Payments
NPI 1467903674 · ELIZABETHTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 37 payments from 9 companies in 2025. Trend: 2023 $210 · 2024 $853 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $330 |
| Lilly USA, LLC | 6 | $118 |
| GlaxoSmithKline, LLC. | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| ABBVIE INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Medtronic, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, MOUNJARO, TRINTELLIX, QULIPTA, FARXIGA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
